Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-24 @ 7:38 PM
Ignite Modification Date:
2025-12-24 @ 7:38 PM
NCT ID:
NCT01152203
Brief Title:
Bendamustine and Bevacizumab for Advanced Cancers
Official Title:
A Phase I Study of Bendamustine and Bevacizumab for Patients With Advanced Cancers
Study:
NCT01152203
Protocol Section:
NCT01152203